Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-034400

Director acquired 8,229 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

TARNOW MICHAEL M · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Exercise or conversion : show line 1 in the form +2,057 $3.87 $7,961 71,770 D
2021-05-18 Exercise or conversion : show line 2 in the form +1,028 $3.67 $3,773 72,798 D
2021-05-18 Exercise or conversion : show line 3 in the form +5,144 $3.67 $18,878 77,942 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-05-18 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −2,057 0 D
2021-05-18 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,028 0 D
2021-05-18 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,144 0 D
Loading xslF345X03/doc4.xml…